Pancreatic Cancer Research

ResearcherNew York UniversityActive in the last 2 years

Brian E. Diskin

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4954-794X; OpenAlex author ID A5102773023. Sources: OpenAlex.

Their work

Papers
7
Trials
0
Grants
0
Labs led
0
Collaborators
39
Papers, trials and grants by year

2018: 1 paper · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 2 papers · 2024: 1 paper · 2025: 2 papers

Papers 7

  1. SMAD4 Alterations are a Predictive Biomarker to Guide First-line Chemotherapy Selection for the Neoadjuvant Treatment of Localized Pancreatic Cancer : A Multic… Co-author DOI 10.1097/sla.0000000000006966↗
  2. Two-Stage Mayo Clinic Class IIIb Celiac Axis Resection for Pancreatic Adenocarcinoma: Stepwise Management. Co-author DOI 10.1245/s10434-024-16673-z↗
  3. The impact of metastatic sites on survival Rates and predictors of extended survival in patients with metastatic pancreatic cancer. Co-author DOI 10.1016/j.pan.2024.06.004↗
  4. Correction to: BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer. Co-author DOI 10.1038/s41388-023-02606-9↗
  5. The critical immune basis for differential responses to immunotherapy in primary versus metastatic pancreatic cancer. Co-author DOI 10.18632/oncotarget.28373↗
  6. BTLA+CD200+ B cells dictate the divergent immune landscape and immunotherapeutic resistance in metastatic vs. primary pancreatic cancer. Co-author DOI 10.1038/s41388-022-02425-4↗
  7. The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression. Co-author DOI 10.1158/2159-8290.cd-17-1134↗

Closest collaborators

The 25 strongest of 39 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. George Miller · 4 shared papers, 2018–2023 · strength 0.60
  2. Daniel Brock Hewitt · 2 shared papers, 2024–2025 · strength 0.41
  3. Greg D. Sacks · 2 shared papers, 2024–2025 · strength 0.41
  4. Ammar A. Javed · 2 shared papers, 2024–2025 · strength 0.41
  5. Deirdre Jill Cohen · 3 shared papers, 2018–2023 · strength 0.29
  6. Berk Aykut · 3 shared papers, 2018–2023 · strength 0.29
  7. Gregor Werba · 3 shared papers, 2018–2023 · strength 0.29
  8. Wei Wang · 2 shared papers, 2022–2023 · strength 0.24
  9. Joshua Leinwand · 2 shared papers, 2022–2023 · strength 0.24
  10. Jonathan Garnier · 1 shared paper, 2025 · strength 0.23
  11. Camila Hidalgo Salinas · 1 shared paper, 2025 · strength 0.23
  12. Christopher L. Wolfgang · 1 shared paper, 2025 · strength 0.23
  13. Alessio Marchetti · 1 shared paper, 2025 · strength 0.23
  14. Julia Button · 1 shared paper, 2025 · strength 0.19
  15. Erin M. Dickey · 1 shared paper, 2025 · strength 0.19
  16. David G. Brauer · 1 shared paper, 2025 · strength 0.19
  17. Caitlin A. Hester · 1 shared paper, 2025 · strength 0.19
  18. Michael E. Lidsky · 1 shared paper, 2025 · strength 0.19
  19. Elishama N. Kanu · 1 shared paper, 2025 · strength 0.19
  20. Ethan S. Agritelley · 1 shared paper, 2025 · strength 0.19
  21. Emil Lou · 1 shared paper, 2025 · strength 0.19
  22. Nipun B. Merchant · 1 shared paper, 2025 · strength 0.19
  23. Daniel P. Nussbaum · 1 shared paper, 2025 · strength 0.19
  24. Brett Logan Ecker · 1 shared paper, 2025 · strength 0.19
  25. Susanna Varkey Ulahannan · 1 shared paper, 2025 · strength 0.19

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.